CClinicalTrials.gg
CompletedNCT06289972Updated Mar 21, 2025

Development,Validity and Reliability of a Caregiver Version of the Breathlessness Beliefs Questionnaire

An observational study in Cystic Fibrosis and Parents, sponsored by Halic University. Completed at 1 site in Turkey. Open to participants aged 25 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-03-21.

Sponsored by Halic University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
42
Ages
25 Years to 75 Years
Sex
All
01

Study summary

The goal of this methodological study is to determine the reliability and validity of the The Breathlessness Beliefs Questionnaire Caregiver Version (BBQ-C) version in assessing dysfunctional breathlessness beliefs in caregivers of children with cystic fibrosis.

Read the detailed description

Cystic fibrosis (CF) is an inherited disease characterized by pulmonary involvement. Children with CF may have obstructive lung disease and related dyspnea, which may progress to respiratory failure and mortality. Dyspnea may lead to activity limitation. Parents who take care of children with CF may be protective of their children's social environment for some reasons such as the risk of infection. The Breathlessness Beliefs Questionnaire (BBQ) is a Turkish validated scale developed to assess dysfunctional beliefs about dyspnea. Based on the idea that parents may develop dysfunctional dyspnea belief behavior in their children with CF, the aim of this study was to develop a caregiver version of the BBQ (The Breathlessness Beliefs Questionnaire Caregiver Version-BBQ-C) and to investigate the validity and reliability of the scale in assessing dysfunctional dyspnea beliefs in parents of children with CF.

02

Conditions studied

  • Cystic Fibrosis
  • Parents
03

In context

Cystic Fibrosis

1,581 studies on the registry are indexed under Cystic Fibrosis; 190 are open to participants now.

This study's enrollment of 42 is below the median of 85 across 482 observational studies indexed under Cystic Fibrosis.

Browse Cystic Fibrosis studies →

Lead sponsor

Halic University is the lead sponsor of 80 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The population of the study will consist of parents of CF patients who come to the Pediatric Chest Diseases Outpatient Clinic of a private hospital for routine control. The sample will consist of parents who fulfill the inclusion and exclusion criteria and volunteer to participate in the study.

Inclusion criteria

  • To be between 25-75 years old,
  • To be literate in Turkish,
  • Being a mother, father or other caregiver of a child,
  • Voluntarily agreeing to participate in the study,
  • Be taking care of the child for at least one year

Exclusion criteria

Exclusion Criteria:

  • Having cognitive impairment at a level that prevents cooperation with the scales,
  • Not living in the same household with a child with cystic fibrosis.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
42 participants (actual)
Target follow-up
15 Days
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. The Breathlessness Beliefs Questionnaire (Caregiver Version) (BBQ-C)

    The BBQ-C will assess dysfunctional dyspnea beliefs in caregivers.The questionnaire has a minimum score of 11 and a maximum score of 55. As the total score increases, the belief in dysfunctional dyspnea increases.

    Time frame: baseline, after 15 days

Secondary outcomes

  1. Cystic Fibrosis Questionnaire Revised (CFQ-R) for parent version

    The CFQ-R assesses quality of life. The CFQ-R is a cystic fibrosis-specific scale developed separately for both the child and the parent. The parent version consists of 50 items. Scores for each HRQoL domain; after recoding, each item is summed to generate a domain score and standardized. Scores range from 0 to 100, with higher scores indicating better health. CD-Rom Program available for scoring the CFQ-R.

    Time frame: baseline, after 15 days

  2. Parent Attitude Scale (PAS)

    The PAS is assess to perceived parental attitude according to child.The scale has three sub-dimensions: acceptance/affection, control/supervision and psychological autonomy. Accordingly, since the scale is scored as Always 5; Mostly 4; No opinion 3; Occasionally 2; Never 1, the individual to whom the scale is applied receives a minimum score of 15 and a maximum score of 75 from each dimension separately. Each dimension is evaluated according to whether the scores are low or high. In whichever dimension the score is higher, it is accepted that the child perceives parental attitude in that way.

    Time frame: baseline, after 15 days

  3. Perceived Social Support Scale (PSS)

    The PSS is assess to perceived social support according to child. The scale includes 5 items on social support perceived from mother and 5 items on social support perceived from father, and 4 items on social support perceived from peers. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. As the total score increases, the child's perception of social support increases.

    Time frame: baseline, after 15 days

  4. Parent Attitude Scale

    Parent Attitude Scale is assess to perceived parental attitude according to parent. Democratic (17 items), Authoritarian (11 items), Overprotective (9 items), Permissive (9 items). In scoring, scores and corresponding responses were 5 for "always", 4 for "most of the time", 3 for "sometimes", 2 for "rarely" and 1 for "never". Having a high score meant to adopt the behavior style represented by that domain.

    Time frame: baseline, after 15 days

07

Study locations

1 site
  • Haliç University
    Istanbul, Eyup 34060, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06289972
Lead sponsor
Halic University
Responsible party
Seda Saka (Asst. Prof., Halic University) — Principal investigator
First posted
Mar 4, 2024
Start date
Feb 20, 2024
Primary completion
Jul 11, 2024
Completion
Jul 11, 2024
Last update
Mar 21, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion